Published in Clin Sci Mol Med Suppl on December 01, 1976
Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Arch Intern Med (2010) 2.58
Potential autonomic risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study. J Pain (2011) 1.32
Denervation of carotid baro- and chemoreceptors in humans. J Physiol (2003) 1.15
Methods for the assessment of the effects of drugs on the arterial system in man. Br J Clin Pharmacol (1979) 0.87
Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA (2001) 4.75
Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med (1991) 2.44
Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation (1986) 2.38
Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol (2001) 2.26
Usefulness of cardiac troponin I in patients undergoing open heart surgery. Am Heart J (2001) 2.26
Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Am Heart J (1973) 2.17
Home blood pressure determination. Value in borderline ("labile") hypertension. JAMA (1974) 2.16
Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol (1995) 2.15
Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med (1993) 2.15
A photonumeric scale for the assessment of cutaneous photodamage. Arch Dermatol (1992) 2.11
Pruritus associated with nocturnal wakenings: organic or psychogenic? J Am Acad Dermatol (1989) 2.06
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press (1993) 2.03
The present medical database needs reorganization. It's time for a change! Arch Intern Med (1990) 2.02
Reference values for self-recorded blood pressure: a meta-analysis of summary data. Arch Intern Med (1998) 2.01
Cyclosporine improves psoriasis in a double-blind study. JAMA (1986) 1.95
Human ageing and the sympathoadrenal system. J Physiol (2000) 1.93
Cardiac sympathetic nerve function in congestive heart failure. Circulation (1996) 1.84
Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. Eur Heart J (2001) 1.75
Home blood pressure monitoring. Arch Intern Med (2000) 1.71
Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. Arch Gen Psychiatry (1998) 1.70
Effect of topical cyclosporine rinse on oral lichen planus. A double-blind analysis. N Engl J Med (1990) 1.68
Sulfasalazine therapy for psoriatic arthritis: a double blind, placebo controlled trial. J Rheumatol (1995) 1.68
Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study. JAMA (1988) 1.65
Effect of sunlight and season on serotonin turnover in the brain. Lancet (2002) 1.63
Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med (2001) 1.63
High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med (1999) 1.62
Sympathetic activation triggers ventricular arrhythmias in rat heart with chronic infarction and failure. Cardiovasc Res (1999) 1.62
Alcohol intake and treatment responsiveness of psoriasis: a prospective study. J Am Acad Dermatol (1993) 1.60
Levels of anxiety in colonic disorders. N Engl J Med (1973) 1.60
Type II diabetes, essential hypertension, and obesity as "syndromes of impaired genetic homeostasis": the "thrifty genotype" hypothesis enters the 21st century. Perspect Biol Med (1998) 1.57
Heart rate and the cardiovascular risk. J Hypertens (1997) 1.57
Renal noradrenaline spillover correlates with muscle sympathetic activity in humans. J Physiol (1996) 1.54
Sulfasalazine improves psoriasis. A double-blind analysis. Arch Dermatol (1990) 1.53
Oral cyclosporine for severe chronic idiopathic urticaria and angioedema. J Am Acad Dermatol (1991) 1.52
Panic disorder: coronary spasm as a basis for cardiac risk? Med J Aust (1998) 1.51
A morphometric and histologic study of the scalp in psoriasis. Paradoxical sebaceous gland atrophy and decreased hair shaft diameters without alopecia. Arch Dermatol (1989) 1.51
Ciclosporin in psoriasis clinical practice: an international consensus statement. Br J Dermatol (2004) 1.51
Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: a LIFE substudy. J Hum Hypertens (2003) 1.51
Cyclosporine in dermatology. J Am Acad Dermatol (1989) 1.50
Effect of changing levels of physical activity on blood-pressure and haemodynamics in essential hypertension. Lancet (1986) 1.50
Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens (2005) 1.49
Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension (1993) 1.48
Proceedings of the Psoriasis Combination and Rotation Therapy Conference. Deer Valley, Utah, Oct. 7-9, 1994. J Am Acad Dermatol (1996) 1.45
Lead, hypertension, and the renin-angiotensin system in rats. J Lab Clin Med (1982) 1.45
Behçet's disease. Int J Dermatol (1984) 1.45
Bulimia nervosa and acne may be related: a case report. Can J Psychiatry (1992) 1.44
Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial. J Hum Hypertens (2008) 1.44
Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects. J Am Coll Cardiol (2001) 1.44
Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation (1994) 1.43
The 'adrenaline hypothesis' of hypertension revisited: evidence for adrenaline release from the heart of patients with essential hypertension. J Hypertens (2000) 1.42
Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials (1996) 1.42
Inocoterone and acne. The effect of a topical antiandrogen: results of a multicenter clinical trial. Arch Dermatol (1992) 1.41
Cyclosporine in the treatment of psoriatic arthritis. Arch Dermatol (1989) 1.41
Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol (1994) 1.39
Increased plasma dihydroxyphenylalanine during sympathetic activation in humans is related to increased norepinephrine turnover. J Lab Clin Med (1991) 1.39
Sulfasalazine: a potential psoriasis therapy? J Am Acad Dermatol (1989) 1.39
Lymphocytic infiltrates of the skin in association with cyclosporine therapy. J Am Acad Dermatol (1990) 1.39
Suicidal ideation in psoriasis. Int J Dermatol (1993) 1.37
Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis. Arch Dermatol (1990) 1.33
Neural mechanisms in human obesity-related hypertension. J Hypertens (1999) 1.30
Diagnostic significance of abdominal murmurs. N Engl J Med (1967) 1.29
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. Am J Hypertens (1997) 1.28
Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension. Acta Med Scand (1974) 1.28
Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med (1994) 1.25
Retinoid therapy is associated with excess granulation tissue responses. J Am Acad Dermatol (1983) 1.23
Relationship between cardiac output and peripheral resistance in borderline hypertension. Circulation (1971) 1.23
Influence of age on the hemodynamic response to exercise. Circulation (1967) 1.22
Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. Hypertension (1997) 1.22
Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. J Clin Endocrinol Metab (1999) 1.21
Evaluation of practolol in hypertension. Effects on sympathetic nervous system and renin responsiveness. Br Heart J (1973) 1.18
Mild high-renin essential hypertension. Neurogenic human hypertension? N Engl J Med (1977) 1.18
Psoriatic epidermal cells demonstrate increased numbers and function of non-Langerhans antigen-presenting cells. J Invest Dermatol (1989) 1.17
Hepatojugular reflux: useful in the bedside diagnosis of tricuspid regurgitation. Ann Intern Med (1984) 1.16
Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation (1993) 1.16
Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation (1971) 1.15
Lymphocytes and macrophages of the epidermis and dermis in lesional psoriatic skin, but not epidermal Langerhans cells, are depleted by treatment with cyclosporin A. Arch Dermatol Res (1989) 1.15
Pruritus in psoriasis. A prospective study of some psychiatric and dermatologic correlates. Arch Dermatol (1988) 1.15
Reduced myocardial nerve growth factor expression in human and experimental heart failure. Circ Res (2000) 1.14
Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol (1994) 1.13
Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial. Br J Dermatol (1993) 1.12
Exercise training lowers resting renal but not cardiac sympathetic activity in humans. Hypertension (1991) 1.11
Hemodynamic studies in patients with borderline blood pressure elevation. Circulation (1968) 1.11
Physiologic skin changes in pregnancy. J Am Acad Dermatol (1984) 1.10
Noradrenaline release and sympathetic nervous system activity. J Hypertens (1985) 1.10
Hemodynamic responses to tilt and beta-adrenergic blockade in young patients with borderline hypertension. Circulation (1970) 1.10
Ninety-minute accelerated critical pathway for chest pain evaluation. Am J Cardiol (2001) 1.10
Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation (1994) 1.10
Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End point. J Am Coll Cardiol (2001) 1.10
Relationships between metrics of visit-to-visit variability of blood pressure. J Hum Hypertens (2013) 1.08
The protective effects of dietary fish oil on focal cerebral infarction. Prostaglandins Med (1979) 1.08
Easy money? Health cost savings resulting from the switch from a branded drug to a low-cost generic drug in the same class. Int J Clin Pract (2011) 1.07
Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators. Hypertension (2000) 1.07
Artefacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatment-resistant hypertension. Ann Intern Med (1990) 1.06
Association of tachycardia with morbidity and mortality: pathophysiological considerations. J Hum Hypertens (1997) 1.06
Fibrin glue treatment of low rectal and pouch-anal anastomotic sinuses. Dis Colon Rectum (2004) 1.04
Effect of beta-adrenergic blockade on plasma volume in human subjects. Proc Soc Exp Biol Med (1972) 1.03
Externalization of beta-adrenergic receptors promoted by myocardial ischemia. Science (1985) 1.03